Opella Re-activates Bisolvon Cough Syrup Production in Brazil
Opella announced on July 28, 2025, that it has re-activated the manufacturing of Bisolvon Adult and Junior cough syrups in Brazil. The products' commercialization is now normalized.
Opella has resumed production of its Bisolvon Adult (8mg/5ml) and Bisolvon Junior (4mg/5ml) cough syrups in Brazil. The company filed the reactivation notification with Brazil's National Health Surveillance Agency (ANVISA) on July 28, 2025.
Following the manufacturing restart, the commercialization of these products has been normalized. Opella noted that delivery logistics may vary by region and advised consumers to check product availability in their local areas.
For further information, consumers can contact Opella's customer service. The company stated that distribution channels are returning to normal, but advised consumers to verify local stock.